🔗 Share this article

As the US undertakes sweeping changes to its vaccination guidelines, a particular individual has surfaced somewhat surprisingly: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who initially gained attention by casting doubt on Covid vaccinations in the global health crisis and has zeroed in on possible fatalities following Covid vaccination in her brief tenure at the Food and Drug Administration.

Planned Shifts to Pediatric Vaccine Program

Agency leaders had intended to unveil sweeping revisions to the pediatric immunization program earlier this month, bringing the US with Denmark’s immunization schedule, according to reports – a significant shift that would place the US out of alignment with many the world with little proof for benefit. The planned update has been delayed until the next year.

Instead of the top vaccines chief, Høeg is listed to speak at the gathering. She was newly appointed interim head of the FDA’s CDER, the fifth person to run the division this calendar year.

A Shift at the Agency

This interim role could signify a strengthened alliance between the drug and biologics divisions as Dr. Høeg and Prasad strengthen their influence at the FDA – and it points to a greater focus upon dismantling long-standing immunizations at the FDA.

Høeg has frequently advocated for discontinuing certain pediatric immunization guidelines in the US in order to be more similar to Denmark, a country with nationalized medicine and a citizenry roughly the size of the state of Wisconsin.

So far statements, she has continued to focus on immunizations – traditionally the responsibility of Dr. Prasad, chief of the FDA’s vaccine center – instead of drug regulation.

Doubts Over Qualifications

The appointee has no obvious background in pharmaceutical research, regulation or management, which has been standard for former leaders of the biologics center. She has served at the FDA as a key advisor to the FDA chief and CBER since spring.

“She appears not to have the requisite experience” for overseeing the CDER, stated a neurologist and psychiatrist. “She has not conducted a scientific study. She is not versed in running a major agency. She is not an expert in pharmaceutical oversight.”

Past directors of the center would “grasp legal statutes and the science of pharmaceutical innovation”, said Dr. Janet Woodcock. “Clearly, she doesn’t have the type of experience that prior appointees who led CBER have had.”

The drug center has an enormous portfolio at the agency, Woodcock pointed out.

“Everybody just focuses on the novel medication approvals, but the off-patent medication office clears thousands of off-brand pharmaceuticals. There’s a biosimilars division, over-the-counter program and more, and all of those must be managed,” she noted. “The area you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Furthermore, a major leadership aspect to the position, which oversees more than 5,000 staff members. “It’s a massive administrative position, if you execute it properly,” she concluded.

Official Statement and Disputed Programs

In response to questions about Høeg’s fitness for the role and whether this assignment indicates more teamwork among regulatory chiefs on immunizations, a representative stated that the “questions are based on inaccurate assumptions”.

“This background is consistent with the duties of her role,” the representative explained, noting the time Dr. Høeg spent guiding the FDA commissioner on “medication safety and oversight research, including computational safety modeling and shot safety tracking”.

In her interim role, Dr. Høeg takes over the agency head's recently launched fast-track approval initiative, a contentious expedited therapy clearance system that apparently concerned her predecessors. “How are these therapies being selected for this voucher program? Who makes the choices?” Dr. Howard said. “There is a lot of confidentiality going on at the FDA right now.”

In general, he remarked, “the Food and Drug Administration looks to be trending towards less stringent regulations of most medications, except for immunizations.”

Documented History on Vaccines

With vaccines, Høeg has a more documented, if troubling, history, Howard have noted. She published a analysis using unverified public submissions to assess the rate of heart inflammation after Covid immunization. She consulted for the state of Florida chief medical officer Dr. Joseph Ladapo, who reportedly have changed statistics to suggest Covid vaccinations are pose a greater threat than they are.

Included in her “policy goals” for the current government encompassed changing regulations for new vaccines and discontinuing “non-essential” immunizations, she stated post-election on a podcast. At the agency, Høeg has allegedly proposed excluding adolescent males from receiving COVID-19 vaccinations.

“She is an thorough dogmatist who starts off with her conclusions and works backwards to accommodate the data in a highly deceptive, dishonest way,” Dr. Howard argued.

Consolidating Power and a “Revenge Tour”

Dr. Høeg became part of other dissenters, {like|